Ng Kamela Charmaine, Meehan Conor Joseph, Torrea Gabriela, Goeminne Léonie, Diels Maren, Rigouts Leen, de Jong Bouke Catherine, André Emmanuel
Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Pôle de Microbiologie Médicale, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
JMIR Med Inform. 2018 Feb 27;6(1):e12. doi: 10.2196/medinform.9309.
Tuberculosis (TB) is the highest-mortality infectious disease in the world and the main cause of death related to antimicrobial resistance, yet its surveillance is still paper-based. Rifampicin-resistant TB (RR-TB) is an urgent public health crisis. The World Health Organization has, since 2010, endorsed a series of rapid diagnostic tests (RDTs) that enable rapid detection of drug-resistant strains and produce large volumes of data. In parallel, most high-burden countries have adopted connectivity solutions that allow linking of diagnostics, real-time capture, and shared repository of these test results. However, these connected diagnostics and readily available test results are not used to their full capacity, as we have yet to capitalize on fully understanding the relationship between test results and specific rpoB mutations to elucidate its potential application to real-time surveillance.
We aimed to validate and analyze RDT data in detail, and propose the potential use of connected diagnostics and associated test results for real-time evaluation of RR-TB transmission.
We selected 107 RR-TB strains harboring 34 unique rpoB mutations, including 30 within the rifampicin resistance-determining region (RRDR), from the Belgian Coordinated Collections of Microorganisms, Antwerp, Belgium. We subjected these strains to Xpert MTB/RIF, GenoType MTBDRplus v2.0, and Genoscholar NTM + MDRTB II, the results of which were validated against the strains' available rpoB gene sequences. We determined the reproducibility of the results, analyzed and visualized the probe reactions, and proposed these for potential use in evaluating transmission.
The RDT probe reactions detected most RRDR mutations tested, although we found a few critical discrepancies between observed results and manufacturers' claims. Based on published frequencies of probe reactions and RRDR mutations, we found specific probe reactions with high potential use in transmission studies: Xpert MTB/RIF probes A, Bdelayed, C, and Edelayed; Genotype MTBDRplus v2.0 WT2, WT5, and WT6; and Genoscholar NTM + MDRTB II S1 and S3. Inspection of probe reactions of disputed mutations may potentially resolve discordance between genotypic and phenotypic test results.
We propose a novel approach for potential real-time detection of RR-TB transmission through fully using digitally linked TB diagnostics and shared repository of test results. To our knowledge, this is the first pragmatic and scalable work in response to the consensus of world-renowned TB experts in 2016 on the potential of diagnostic connectivity to accelerate efforts to eliminate TB. This is evidenced by the ability of our proposed approach to facilitate comparison of probe reactions between different RDTs used in the same setting. Integrating this proposed approach as a plug-in module to a connectivity platform will increase usefulness of connected TB diagnostics for RR-TB outbreak detection through real-time investigation of suspected RR-TB transmission cases based on epidemiologic linking.
结核病是全球致死率最高的传染病,也是与抗菌药物耐药性相关的主要死因,但其监测仍采用纸质记录。耐利福平结核病(RR-TB)是一场紧迫的公共卫生危机。自2010年以来,世界卫生组织认可了一系列快速诊断检测(RDT),这些检测能够快速检测耐药菌株并产生大量数据。与此同时,大多数高负担国家已采用连接解决方案,可实现诊断设备的连接、这些检测结果的实时获取以及共享存储。然而,这些连接的诊断设备和现成的检测结果并未得到充分利用,因为我们尚未充分利用对检测结果与特定rpoB突变之间关系的理解来阐明其在实时监测中的潜在应用。
我们旨在详细验证和分析RDT数据,并提出连接诊断设备及相关检测结果在RR-TB传播实时评估中的潜在用途。
我们从比利时安特卫普的比利时微生物协调保藏中心选取了107株携带34种独特rpoB突变的RR-TB菌株,其中30种在利福平耐药决定区(RRDR)内。我们对这些菌株进行了Xpert MTB/RIF、GenoType MTBDRplus v2.0和Genoscholar NTM + MDRTB II检测,并根据菌株现有的rpoB基因序列对检测结果进行了验证。我们确定了结果的可重复性,分析并可视化了探针反应,并提出将其用于评估传播的潜在用途。
RDT探针反应检测出了大多数测试的RRDR突变,尽管我们发现观察结果与制造商声明之间存在一些关键差异。根据已发表的探针反应频率和RRDR突变情况,我们发现了在传播研究中具有高度潜在用途的特定探针反应:Xpert MTB/RIF探针A、B延迟、C和E延迟;GenoType MTBDRplus v2.0的WT2、WT5和WT6;以及Genoscholar NTM + MDRTB II的S1和S3。对有争议突变的探针反应进行检查可能有助于解决基因型和表型检测结果之间的不一致。
我们提出了一种通过充分利用数字连接的结核病诊断设备和检测结果共享存储库来实时检测RR-TB传播的新方法。据我们所知,这是针对2016年世界著名结核病专家关于诊断连接在加速结核病消除努力方面潜力的共识所开展的第一项务实且可扩展的工作。我们提出的方法能够促进同一环境中使用的不同RDT之间的探针反应比较,这证明了该方法的有效性。将此方法作为插件模块集成到连接平台中,将通过基于流行病学关联对疑似RR-TB传播病例进行实时调查,提高连接的结核病诊断设备在RR-TB疫情检测中的实用性。